Page 2,019«..1020..2,0182,0192,0202,021..2,0302,040..»

How to tell good stem cells from the bad: Yale researchers answer key question

Posted: September 5, 2014 at 1:50 am

The promise of embryonic stem cell research has been thwarted by an inability to answer a simple question: How do you know a good stem cell from a bad one?

Yale researchers report in the Sept. 4 issue of the journal Cell Stem Cell that they have found a marker that predicts which batch of personalized stem cells will develop into a variety of tissue types and which will develop into unusable placental or tumor-like tissues.

Scientists have been unable to capitalize on revolutionary findings in 2006 that adult cells could be made young again with the simple introduction of four factors. Hopes were raised that doctors would soon have access to unlimited supplies of a patients own iPSCs induced pluripotent stem cells that could be used to repair many types of tissue damage. However, efforts to direct these cells to therapeutic goals have proved difficult. Many attempts to use cells clinically have failed because they form tumors instead of the desired tissue.

The team of Yale Stem Cell Center researchers led by senior author Andrew Xiao identified a variant histone a protein that helps package DNA which can predict the developmental path of iPSC cells in mice. An accompanying paper in the same journal by researchers at the Whitehead Institute at MIT and Hebrew University in Israel also identifies at different marker that also appears to predict stem cell fate.

The trend is to raise the standards and quality very high, so we can think about using these cells in clinic, Xiao said. With our assay, we have a reliable molecular marker that can tell what is a good cell and what is a bad one.

Lead author of the paper is Tao Wu of Yale.

Research is funded by Yale and Connecticut Stem Cell Foundation.

Visit link:
How to tell good stem cells from the bad: Yale researchers answer key question

Posted in Connecticut Stem Cells | Comments Off on How to tell good stem cells from the bad: Yale researchers answer key question

Alaska Patient Consults Dr.Lox on Stem Cell Therapy – Dr Lox

Posted: September 5, 2014 at 1:49 am

Alaska Patient Consults Dr.Lox on Stem Cell Therapy

Tampa, Saint Petersburg and Clearwater, FL

Dr. Dennis Lox, a sports and regenerative specialist in the Tampa Bay, Florida area, has seen and been consulted by patients in many foreign countries. But, when a patient in Alaska consulted him for stem cell therapy treatment it represented the furthest state in the United States to consult him. He has seen many patients from other states but Alaska is now the most distant to consult Dr.Lox. It is an honor and privilege to care for patients, yet having patients travel great distances and inconveniences to be under the care of Dr. Lox is truly an honor he respects. His staff makes every effort to accommodate their needs and make the journey and care as pleasant as possible.

Dr. Dennis Loxserves patients in the greater Tampa Bay area, including, Clearwater, St. Petersburg, Tampa, New Port Richey, Sarasota, Orlando and Spring Hill. He has been pleased to accommodate the needs of patients throughout Florida, the United States, the Western Hemisphere, and Europe, as well. Located in the 33765 area, our office can be reached at (727) 462-5582.

View original post here:
Alaska Patient Consults Dr.Lox on Stem Cell Therapy - Dr Lox

Posted in Alaska Stem Cells | Comments Off on Alaska Patient Consults Dr.Lox on Stem Cell Therapy – Dr Lox

Washington Post on Stem Cells – Gerontology Research Group …

Posted: September 5, 2014 at 1:48 am

"NIH: Few Stem Cell Colonies Likely Available for Research" by Justin Gillis and Rick Weiss The Washington Post

March 3, 2004; At least 16 of the 78 human stem cell colonies approved by President Bush for Federal research money have died or failed to reproduce in their laboratory dishes -- making them useless to scientists -- and most of the others are unlikely ever to become available for disease research, according to interviews and a new analysis by the National Institutes of Health. The unpublished NIH analysis, circulating yesterday on Capitol Hill, said only about one-quarter of the Bush-approved cell colonies are ever likely to be available, far fewer than supporters of the President's policy had predicted. Moreover, several of the Bush-approved colonies available to researchers are beginning to show genetic abnormalities, potentially undermining their medical usefulness, researchers said. Advocates of stem-cell research, who believe it offers possibilities for curing a range of diseases from diabetes to Parkinson's, said these developments confirmed fears they expressed in 2001, when Bush announced that he would allow Federal funding only for stem-cell colonies that had been extracted from human embryos as of August 9, 2001.

Two Democrats, Reps. Henry A. Waxman (CA) and Louise M. Slaughter (NY), yesterday accused the Administration of misleading the public by continuing to contend that the policy allows for robust scientific research. In a stinging letter to the White House, they declared that the new NIH analysis "casts into doubt the adequacy of your policy on stem-cell research."

A bipartisan group of House members -- including some Republicans who until now accepted the Bush policy -- are gathering signatures on a letter of their own calling for a policy change. Sensing that the tide may be shifting in their favor, scientific organizations have stepped up their campaign to ease restrictions on the controversial research, which uses embryos slated for destruction by fertility clinics. "I think the administration has been trying to implement the existing policy in good faith," said Lawrence Soler of the Juvenile Diabetes Research Foundation, which supports expanding Federally-funded research. "I think it's just come to a point now of having to face that we're not as far as we had hoped we'd be -- or even, we believe, where the Administration had hoped we'd be."

The Administration said it was planning no change of policy. "The president remains committed to exploring the promise of stem cell research but continues to firmly believe that we should not cross a fundamental moral line by funding or encouraging the destruction of human embryos," said White House spokesman Trent Duffy.

The debate centers on a policy that has been among the most contentious of Bush's tenure. Democrats have generally been united in supporting broad research on embryonic stem cells, while the Republican majority in Congress has been sharply divided.

Scientists are excited about the cells because, unlike most adult cells, they can morph into nearly any tissue in the human body. Researchers hope to grow large numbers of cells in the laboratory and then coax them into becoming brain cells that might cure Parkinson's Disease, pancreatic cells to cure diabetes, and so on. But creating a laboratory colony of stem cells requires destroying a five-day-old human embryo. Social conservatives have opposed the work, saying embryo destruction "is tantamount to murder." Torn between this group and disease-research advocates, including former first lady Nancy Reagan, Bush announced a compromise on August 9, 2001, that precluded Federally-funded research on cells from embryos destroyed after that date. That effectively froze the supply at its then-current level.

The president initially said more than 60 colonies would qualify -- a number that surprised many biologists, who had not been aware of colonies created at private companies and foreign laboratories. The large number helped to quell criticism that Bush was limiting a promising field of medicine. As others announced that they, too, had cells from before that date, the number of eligible colonies grew to 78.

But in recent weeks, the NIH has been posting information on the Internet showing that 16 of the colonies "filled to expand into undifferentiated cell cultures." That is biology-speak for saying the cells are useless for further research, though it is not clear how many colonies are dead and how many have simply stopped reproducing.

At one company, CyThera Inc. of San Diego, nine colonies have collapsed, eliminating more than ten percent of the administration's list. So have six colonies at a laboratory in Sweden and one at a company in Athens, GA. It is not unusual for cell colonies to "crash" in biology, particularly in early research, when scientists do not really know how best to grow the cells. Usually, they would simply replace a dead cell colony -- but under Bush's policy, they cannot.

See the original post here:
Washington Post on Stem Cells - Gerontology Research Group ...

Posted in Washington Stem Cells | Comments Off on Washington Post on Stem Cells – Gerontology Research Group …

New protagonist in cell reprogramming discovered

Posted: September 5, 2014 at 1:45 am

PUBLIC RELEASE DATE:

4-Sep-2014

Contact: Laia Cendrs laia.cendros@crg.eu 34-933-160-237 Center for Genomic Regulation

This news release is available in Spanish.

The protein Nanog, a transcription factor, is key to maintaining stem cells in a pluripotent state. Researchers from the Centre for Genomic Regulation have been investigating the role of this protein, and have just published an article in the prestigious journal Cell Reports where they reveal the mechanism whereby Nanog acts. The scientists have discovered that Nanog involves other agents and they have been able to detail their dynamics. In particular, by studying another protein that is also involved in cell reprogramming (beta-catenin) they have been able to improve the knowledge of Nanog's functioning.

Cell renewal is a natural process that takes place constantly in our body. For this to happen, we have stem cells that are responsible for generating new cells to replenish and renew those that die. Stem cells give rise to undifferentiated pluripotent cells which have the ability to become any cell type. These pluripotent cells follow a differentiation path towards specialisation, which can produce any cell type from neurones to skin.

The scientists want to understand the mechanisms that allow stem cells to either differentiate or remain pluripotent. There are also many studies that seek to reverse this process, to enable already differentiated cells to be reprogrammed and become pluripotent. Knowing all the players in these processes is of vital importance for understanding how stem cells work and allowing progress in regenerative medicine.

"We knew that Nanog was somehow involved in keeping stem cells pluripotent; now we know which mechanism it uses and we understand better how it works", explains Luca Marucci, one of the authors of the work from the cell reprogramming and regeneration laboratory at the CRG, led by researcher Pia Cosma. "Studying this process has allowed us to discover not only Nanog's key role in reprogramming, but also the dynamics of another protein, known as beta-catenin. We now know that beta-catenin, just like Nanog, continuously fluctuates in the cell and does not only appear when reprogramming is activated", adds Elisa Pedone, co-author of the work from the same laboratory.

In order to understand and define parameters for the activity of both proteins, the researchers have developed a mathematical model that could explain this dynamic. The model could be useful for understanding the behaviour of these proteins in the cell both over time and in different situations.

We are talking about a basic discovery on the functioning and dynamics of stem cell reprogramming. An ever-more studied process that holds great hope for the medicine of the future. The laboratory at the Centre for Genomic Regulation led by the ICREA research professor, Pia Cosma, is making a definitive contribution to this knowledge. Her group looks at basic mechanisms that orchestrate cell differentiation and reprogramming, right up to concrete reprogramming methods for repairing damage in certain tissues.

Follow this link:
New protagonist in cell reprogramming discovered

Posted in Cell Medicine | Comments Off on New protagonist in cell reprogramming discovered

Research institute to improve treatment for heart diseases

Posted: September 5, 2014 at 1:44 am

SINGAPORE: The Republic now has a research institute to improve treatment and seek cures through research for cardiovascular diseases. The facility was launched on Friday (Sep 5) at the SingHealth Duke-NUS Scientific Congress 2014, a platform to showcase the latest medical developments.

The 4,000-square-meter National Heart Research Institute Singapore is located in the Singapore General Hospital campus, and will focus on areas such as heart function and genetics, and regenerative medicine.

A joint venture by National Heart Centre Singapore and Duke-NUS, the research institute seeks to be a leading facility in cardiovascular research in Singapore and the Asian region. It is helmed by renowned cardiovascular research expert Professor Stuart Cook.

Research efforts were given a boost with a gift of S$3 million from Tanoto Foundation. Of this amount, S$2.5 million will be used to set up the Tanoto Foundation Professorship in Cardiovascular Medicine, and S$500,000 will fund the Tanoto Foundation Initiative for Genetics and Stem Cell research.

NEW MEDICAL BREAKTHROUGHS

At the congress, some of the latest medical developments were showcased. One of the breakthroughs was the discovery of novel genes for age-related cataract, a global leading cause of blindness, by the Singapore Eye Research Institute in partnership with Duke-NUS and the Genome Institute of Singapore at A*STAR.

These findings will improve clinician's understanding of the disease and pave the way for further research on how to target the genes to delay cataract formation. The two-day congress will see more than 2,500 delegates.

Read the original here:
Research institute to improve treatment for heart diseases

Posted in Regenerative Medicine | Comments Off on Research institute to improve treatment for heart diseases

Congenital Hypotonia | Stem Cell Treatment | My Story – Video

Posted: September 4, 2014 at 6:42 pm


Congenital Hypotonia | Stem Cell Treatment | My Story
Saif and his mother, like many other families, were left with no hope after Saif was diagnosed with Benign Congenital Hypotonia, a muscle weakness disease similar to Muscular Dystrophy. Local...

By: Repair Stem Cells

See more here:
Congenital Hypotonia | Stem Cell Treatment | My Story - Video

Posted in Stem Cell Videos | Comments Off on Congenital Hypotonia | Stem Cell Treatment | My Story – Video

3 Sep 2014 cryogenically stored stem cells but are they worth it? #multiplesclerosis – Video

Posted: September 4, 2014 at 6:42 pm


3 Sep 2014 cryogenically stored stem cells but are they worth it? #multiplesclerosis
http://facebook.com/MSVideoDiary I posted a link earlier to an article claiming that a cure is close but I hear that all the time! and one part of the articl...

By: Andy Bailey

Excerpt from:
3 Sep 2014 cryogenically stored stem cells but are they worth it? #multiplesclerosis - Video

Posted in Stem Cell Videos | Comments Off on 3 Sep 2014 cryogenically stored stem cells but are they worth it? #multiplesclerosis – Video

Long term Culture of Haematopoietic Stem cells and Red blood Cells Production – Video

Posted: September 4, 2014 at 6:42 pm


Long term Culture of Haematopoietic Stem cells and Red blood Cells Production
Reprogramming human leukocytes into haematopoietic stem cells capable of generating red blood cells and Platelets in long term culture via a process of retro...

By: Ilham Abuljadayel

Read the rest here:
Long term Culture of Haematopoietic Stem cells and Red blood Cells Production - Video

Posted in Stem Cell Videos | Comments Off on Long term Culture of Haematopoietic Stem cells and Red blood Cells Production – Video

biology stem cells – Video

Posted: September 4, 2014 at 6:42 pm


biology stem cells

By: Carlos Bonilla

Originally posted here:
biology stem cells - Video

Posted in Stem Cell Videos | Comments Off on biology stem cells – Video

Indian PM Narendra Modi visits stem cell research lab in Kyoto – Video

Posted: September 4, 2014 at 6:42 pm


Indian PM Narendra Modi visits stem cell research lab in Kyoto
Indian Prime Minister Narendra Modi visits the cutting edge stem cell research lab in Kyoto, on the second day of his official visit.

By: MEA India File

Follow this link:
Indian PM Narendra Modi visits stem cell research lab in Kyoto - Video

Posted in Stem Cell Research | Comments Off on Indian PM Narendra Modi visits stem cell research lab in Kyoto – Video

Page 2,019«..1020..2,0182,0192,0202,021..2,0302,040..»